ArticleAnnals of medicine and surgery (2012)2024

FDA approval of Casgevy and Lyfgenia: a dual breakthrough in gene therapies for sickle cell disease.

Zainab Syyeda Rahmat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.